Physician profile
Ronald E Stella
NPI 1821052093
$11,123.65
in general payments reported to CMS, 2019-2025
26 companies · $360 in 2025
The $360 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $99.24 · 2020: $168 · 2021: $823 · 2022: $446 · 2023: $8,771 · 2024: $456 · 2025: $360.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $8,028 · Food and Beverage: $1,559.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $8,027.95 |
| Food and Beverage | $1,559.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $8,836.11 | 2021-2024 | In.Pact Admiral, Turbohawk, Cobalt Dr Mri Surescan |
| Abbott Laboratories | $695.29 | 2020-2023 | Perclose Prostyle, Supera |
| Novartis Pharmaceuticals Corporation | $204.23 | 2021-2025 | |
| Limflow INC. | $194.33 | 2023 | Limflow System |
| Medtronic Vascular, INC. | $131.82 | 2020 | |
| Novo Nordisk INC | $114.24 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $113.01 | 2019-2025 | Repatha, Repatha |
| Inari Medical, INC. | $107.04 | 2024 | Limflow System |
| Angiodynamics, INC. | $100.86 | 2021 | |
| Boston Scientific Corporation | $98.37 | 2019-2024 | Watchman Flx |
| Janssen Pharmaceuticals, INC | $74.45 | 2021-2024 | Xarelto |
| Kestra Medical Technology Services, INC. | $62.44 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $56.37 | 2019-2022 | |
| Ge Healthcare | $51.59 | 2025 | |
| Scpharmaceuticals INC. | $43.67 | 2024-2025 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $42.52 | 2022 | |
| Atricure, INC. | $38.27 | 2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Siemens Medical Solutions USA, INC. | $26.95 | 2025 | |
| Kiniksa Pharmaceuticals, LTD. | $19.40 | 2023 | Arcalyst |
| Edwards Lifesciences Corporation | $19.24 | 2024 | |
| Pfizer INC. | $18.09 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $17.83 | 2022 | |
| Cardiovascular Systems INC. | $17.60 | 2020 | |
| Endotronix, INC. | $17.22 | 2025 | Cordella Pulomonary Artery Pressure Sensor |
| Tactile Systems Technology INC | $15.53 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $7.18 | 2023 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Stella listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.